Answers are grounded in this paper and cite their sources.
We read with great interest the article by Bert et al.1 about the microbial epidemiology of bloodstream infections (BSIs) after liver transplantation (LT). We would like to comment on this issue on the basis of our results, which support the reemergence of gram-negative (GN) bacteria as a leading cause of BSIs after LT. The use of antibacterial and antifungal prophylaxis through the decades has likely contributed to the emergence of increasingly resistant pathogens that now necessitate alterations in antimicrobial therapy. After the introduction of selective digestive decontamination against GN microorganisms in the mid 1990s, gram-positive (GP) bacteria emerged as major pathogens. However, Singh et al.2 in 2004 and now Bert et al.1 have reported the reemergence of GN bacteremias. We analyzed the occurrence of BSIs in 136 consecutive LT patients (mean age = 49 years) during the first year after LT. The study period was January 2005 to October 2008. We considered BSIs to be significant according to the criteria of the Centers for Disease Control and Prevention: (1) the isolation of a microorganism other than a common skin contaminant in at least 1 blood culture with signs and symptoms of infection or (2) the isolation of a common skin contaminant in at least 2 blood cultures drawn on separate occasions with signs and symptoms of infection.3 Blood cultures were incubated with the BacT/ALERT automated system (BioMerieux, France). Isolates were identified with standard microbiology procedures, and sensitivity testing was performed by disk diffusion according to the standards and interpretation of the Clinical and Laboratory Standards Institute.4 Minimal inhibitory concentrations were determined with Etest (AB Biodisk, Sweden). All patients were treated with perioperative prophylaxis (piperacillin-tazobactam for 5 days) and selective digestive decontamination (gentamicin and fluconazole for 3 days). Standard prophylaxis with trimethoprim-sulfamethoxazole (9 months) for Pneumocystis jiroveci and with valganciclovir (3 months) for cytomegalovirus was given to all patients. Immunosuppression consisted of prednisone induction and a maintenance regimen: prednisone (withdrawal after 3-6 months), calcineurin inhibitors (tacrolimus or cyclosporine), and mycophenolate mofetil. Forty-seven BSIs were identified in 23 transplant patients (16.9%); this represents an incidence of 34.6 episodes per 100 transplant patients. They occurred predominantly in the first trimester (median = 46 days post-LT, range = 0-248 days, standard deviation = 72 days). Polymicrobial bacteremias accounted for 12.8% of cases. Altogether, 53 pathogens were isolated. GN bacilli (predominantly Klebsiella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli) were responsible for 58.5% of BSIs (Table 1). A high incidence (42%) of resistant Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) was observed among BSI isolates (Table 2). Low sensitivity in Enterobacteriaceae was recorded for piperacillin/tazobactam (63%), third-generation cephalosporins (58%), cefepime (58%), gentamicin (47%), amikacin (53%), and ciprofloxacin (21%). We found a high proportion of P. aeruginosa isolates to be resistant to multiple antibiotics, including carbapenems (57%), in our series of patients. The most prevalent GP microorganisms that were isolated were enterococci and coagulase-negative staphylococci (CoNS). In the CoNS cases, all BSIs were catheter-related according to clinical criteria. Methicillin-resistant Staphylococcus aureus (MRSA) was responsible for only 1 BSI. Fungi accounted for a higher proportion of isolates (13.2%) in comparison with other studies in which antifungal prophylaxis was used.5 Most fungemias were caused by Candida albicans(50%), whereas non-albicans species included Candida parapsilosis and Candida tropicalis, which were fluconazole-susceptible. Death occurred within 15 days as a result of BSIs in 8 of the 47 episodes (17%), and it was predominantly associated with ESBL-producing K. pneumoniae(3 cases), carbapenem-insusceptible P. aeruginosa(3 cases), and Candida parapsilosis(2 cases). The only vancomycin-resistant isolate of Enterococcus faecium(vancomycin-resistant enterococci) resulted in a fatal outcome. In 3 patients who died of BSIs, multiple organisms were isolated from blood cultures. In conclusion, our data support the recently described reemergence of GN pathogens as leading agents of BSIs after LT. It is particularly worrisome that a large proportion of GN bacteria causing BSIs are resistant to multiple antibiotics; this not only compromises the empirical therapy of sepsis in LT patients but also leaves few choices in some cases even when the causative agent is known. Carbapenem-resistant nonfermentative bacteria are becoming more prevalent in our unit, and it may be only a matter of time before colistin is no longer effective as a drug of last resort. Rigorous infection control practices should be applied in an attempt to stop the spread of such organisms once they appear on the ward. No less important is the need to rationalize the use of antibiotics, which in many cases are misused in the treatment of bacterial colonization of different sites or are used too long for prophylaxis. The surveillance and analysis of bacteria causing serious infections in defined subsets of patients are essential for interventions aimed at improving the treatment and prophylaxis of infections in these patients. In our case, we will try to reduce the rate of multidrug-resistant GN bacteria by reducing the duration of surgical prophylaxis to 24 to 48 hours and by switching to a narrower spectrum antibiotic. The reinforcement of contact isolation and standard precautions is a process currently underway in our hospital. Mrzljak Anna M.D.*, Peric Zinaida M.D.*, Kovacevic Visnja M.D. , Gustin Denis M.D. , Vrhovac Radovan M.D.*, Tambic Andrasevic Arjana M.D. , * Departments of Medicine, University Hospital Merkur, Zagreb, Croatia, Anesthesiology and Intensive Care, University Hospital Merkur, Zagreb, Croatia, Department of Microbiology, Dr.
No takes yet. Share an insight, caveat, or question.
Mrzljak et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: